Animalcare Group PLC Animalcare announces leadership change (7459W)
03 August 2018 - 4:01PM
UK Regulatory
TIDMANCR
RNS Number : 7459W
Animalcare Group PLC
03 August 2018
3 August 2018
Animalcare Group plc
("Animalcare", the "Company" or the "Group")
Animalcare announces leadership change
Animalcare Group plc (AIM:ANCR), the pan-European animal health
business, today announces that Chris Cardon will step down from his
position as Chief Executive Officer. The Board has appointed Jenny
Winter to succeed Chris as Chief Executive Officer with effect from
1 October 2018. Chris will remain on the Board of the Company as
part of the executive management team, transitioning to Chief
Strategy Officer as of 1 October 2018. Chris will continue to lead
the Company's international strategic vision and acquisition
strategy and be part of Jenny's leadership team.
Jenny joins Animalcare with over twenty years' experience
working in big pharma in various senior commercial roles for
AstraZeneca and GlaxoSmithKline. Most recently, Jenny was
Vice-President of Respiratory products - Global Supply Chain and
Strategy at AstraZeneca, a position she held from 2015. Roles at
the company also include Vice-President Cardiology - Global Product
and Portfolio Strategy, Commercial Director - Eastern Europe,
Marketing Company President Hungary, where she led a major change
programme to drive future success and Global Vice President, Group
Public Affairs.
Jenny has also been CEO of the charity Barretstown, transforming
it into a successful leading children's charity. Her work at the
charity resulted in her being asked by Barretstown board member
Dermot Gleeson, Chairman of Allied Irish Bank, to join the Board of
the bank as a Non-Executive Director, a role she held from 2004 to
2010. Jenny has a BSc in Physiology and Pharmacology from the
University of Southampton.
Jan Boone, Chairman of Animalcare Group plc, said: "We are
excited to welcome Jenny Winter, whose strong and varied
international experience make her ideally placed to continue to
realise the full benefits of the recent reverse merger and continue
to implement our clear strategy for growth in the attractive animal
health market.
"The Board would like to thank Chris for his significant
achievements as Chief Executive, overseeing the transformational
merger with Ecuphar and the transition of Animalcare to an
international animal health business. His extensive experience will
continue to be invaluable to the Company in his new role and will
be vital in the Company's plans for growth."
Jenny Winter, Chief Executive Officer Elect of Animalcare Group
plc, said: "I am delighted to be joining Animalcare at a very
exciting time for the Company. My focus will be on accelerating the
strong foundation for growth that has been already laid by the
Board and management team, focusing on consolidation, product
development and maximising the potential of the Group's unique and
highly compelling animal health portfolio."
Chris Cardon, Chief Executive Officer/Strategy Officer of
Animalcare Group plc, said: "I am proud to have led Animalcare
through a very significant period of development for the business.
I am pleased to hand over the reins of the Company to Jenny to
allow me to focus on the strategic vision for the business and I am
confident that she is the right candidate to lead Animalcare in its
next stage of its growth and development. I look forward to working
with her closely to ensure the continued success of the Group and
to drive sustained growth of the business."
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) No 596/2014.
For further information, please contact:
Animalcare Group plc Tel: 01904 487 687
Chris Cardon, Chief Executive Officer
Chris Brewster, Chief Financial Officer
Panmure Gordon (Nominated Adviser & Broker) Tel: 020 7886 2500
Corporate Finance
Freddy Crossley / Emma Earl
Corporate Broking
James Stearns
Consilium Strategic Communications Tel: 020 3709 5700
Amber Fennell animalcare@consilium-comms.com
Chris Welsh
Olivia Manser
Additional information
In accordance with paragraph (h) of Schedule 2 of the AIM Rules
for Companies, the following information required to be disclosed
in relation to Ms Winter is set out below.
Jennifer Ann Julia Winter (also known as Hynes and
Winter-Hynes), aged 58, is not and has not been a director or
partner of any companies within the previous five years. Also, Ms
Winter currently holds no beneficial interest in the Company.
There is no further information required to be disclosed in
respect of Ms Winter under Rule 17 or paragraph (g) of Schedule 2
of the AIM Rules for Companies.
About Animalcare Group plc
Animalcare is a pan-European sales, marketing and product
development company focused on the veterinary and animal health
sectors. The Company has operations across Europe with direct sales
in seven countries (UK, Belgium, Netherlands, Spain, Portugal,
Italy and Germany), and exports to approximately 40 markets
worldwide through global partnerships. The Company sells over 300
products including pharmaceuticals, vaccines and nutraceuticals.
Animalcare has a diverse pipeline of products in development and a
strong network of distribution and in-license partnerships. For
more information, please visit: www.animalcaregroup.co.uk
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
BOAUGUCWRUPRUAW
(END) Dow Jones Newswires
August 03, 2018 02:01 ET (06:01 GMT)
Animalcare (LSE:ANCR)
Historical Stock Chart
From Apr 2024 to May 2024
Animalcare (LSE:ANCR)
Historical Stock Chart
From May 2023 to May 2024